CY1105365T1 - Μια φαρμακευτικη συνθεση για ελεγχομενη εκλυση ενος αντιβιοτικου της β-λακταμης - Google Patents
Μια φαρμακευτικη συνθεση για ελεγχομενη εκλυση ενος αντιβιοτικου της β-λακταμηςInfo
- Publication number
- CY1105365T1 CY1105365T1 CY20061100721T CY061100721T CY1105365T1 CY 1105365 T1 CY1105365 T1 CY 1105365T1 CY 20061100721 T CY20061100721 T CY 20061100721T CY 061100721 T CY061100721 T CY 061100721T CY 1105365 T1 CY1105365 T1 CY 1105365T1
- Authority
- CY
- Cyprus
- Prior art keywords
- water
- pharmaceutical composition
- active ingredient
- controlled release
- lactam antibiotic
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 2
- 230000003115 biocidal effect Effects 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000003085 diluting agent Substances 0.000 abstract 2
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 abstract 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 abstract 1
- 229960005361 cefaclor Drugs 0.000 abstract 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 abstract 1
- 229940106164 cephalexin Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 abstract 1
- 229960003081 probenecid Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000661 sodium alginate Substances 0.000 abstract 1
- 235000010413 sodium alginate Nutrition 0.000 abstract 1
- 229940005550 sodium alginate Drugs 0.000 abstract 1
- 239000000230 xanthan gum Substances 0.000 abstract 1
- 235000010493 xanthan gum Nutrition 0.000 abstract 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
- 229940082509 xanthan gum Drugs 0.000 abstract 1
- 239000002132 β-lactam antibiotic Substances 0.000 abstract 1
- 229940124586 β-lactam antibiotics Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Μία σταθερή φαρμακευτική σύνθεση για ελεγχόμενη έκλυση ενός ενεργού συστατικού περιέχει ένα αντιβιοτικό της β-λακτάμης όπως κεφαλεξίνη, κεφακλόρη ή τα φαρμακευτικώς αποδεκτά ένυδρα, άλατα ή εστέρες τους ως ενεργό συστατικό, ένα άλας ασβεστίου και ένα μείγμα υδρόφιλων πολυμερών τα οποία επιλέγονται από την ομάδα η οποία αποτελείται από τουλάχιστον ένα αλγινικό νάτριο και ένα ξανθανικό κόμμι και με ή χωρίς υδροξυπροπυλο μεθυλοκυτταρίνη, όπου η εν λόγω σύνθεση προαιρετικά περιέχει προβενεσίδη. Η σύνθεση μπορεί επίσης να περιέχει ένα ή περισσότερα υδατοδιαλυτά και/ή διασπειρόμενα μέσω ύδατος αραιωτικά μέσα, όπου οι ποσότητες των υδρόφιλων πολυμερών και των υδατοδιαλυτών και/ή διασπειρόμενων μέσω ύδατος αραιωτικών μέσων είναι τέτοιες έτσι ώστε το θεραπευτικά αποτελεσματικό ενεργό συστατικό να εκλύεται με ένα ρυθμό κατάλληλο για χορήγηση της φαρμακευτικής σύνθεσης μία ή δύο φορές την ημέρα.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2001/000204 WO2003043607A1 (en) | 2001-11-19 | 2001-11-19 | A pharmaceutical composition for controlled release of a beta-lactam antibiotic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1105365T1 true CY1105365T1 (el) | 2010-03-03 |
Family
ID=11076411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20061100721T CY1105365T1 (el) | 2001-11-19 | 2006-06-05 | Μια φαρμακευτικη συνθεση για ελεγχομενη εκλυση ενος αντιβιοτικου της β-λακταμης |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8192755B2 (el) |
| EP (1) | EP1461017B1 (el) |
| AT (1) | ATE319434T1 (el) |
| AU (1) | AU2002224011B2 (el) |
| BR (1) | BR0117171A (el) |
| CY (1) | CY1105365T1 (el) |
| DE (1) | DE60117712T2 (el) |
| DK (1) | DK1461017T3 (el) |
| ES (1) | ES2259011T3 (el) |
| PT (1) | PT1461017E (el) |
| WO (1) | WO2003043607A1 (el) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
| US8124118B2 (en) | 2003-10-22 | 2012-02-28 | Lidds Ab | Composition comprising biodegradable hydrating ceramics for controlled drug delivery |
| US7807715B2 (en) * | 2006-06-09 | 2010-10-05 | Ucb Pharma Gmbh | Pharmaceutical compositions comprising fesoterodine |
| US9050357B2 (en) * | 2010-03-08 | 2015-06-09 | Cp Kelco U.S., Inc. | Compositions and methods for producing consumables for patients with dysphagia |
| RU2470671C1 (ru) * | 2011-07-06 | 2012-12-27 | Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова Федерального агентства по здравоохранению и социальному развитию" | Способ обработки текстильных изделий для сердечно-сосудистой хирургии |
| CN107661507A (zh) * | 2017-10-30 | 2018-02-06 | 四川飞扬动物药业有限公司 | 兽用肠溶长效复方阿莫西林粉及其制备方法 |
| US11554112B2 (en) * | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
| EA202192193A1 (ru) | 2019-02-13 | 2021-11-09 | Итерум Терапьютикс Интернэшнл Лимитед | Комбинации бета-лактамных соединений и пробенецида и их применения |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6055486B2 (ja) * | 1976-02-28 | 1985-12-05 | 富山化学工業株式会社 | β−ラクタム環を有する化合物の直腸投与用組成物 |
| GB8601204D0 (en) | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
| US5419917A (en) * | 1994-02-14 | 1995-05-30 | Andrx Pharmaceuticals, Inc. | Controlled release hydrogel formulation |
| IL119627A (en) * | 1996-11-17 | 2002-03-10 | Yissum Res Dev Co | PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT |
| US5948440A (en) * | 1997-12-17 | 1999-09-07 | Ranbaxy Laboratories Limited | Modified release matrix formulation of cefaclor and cephalexin |
| EA004443B1 (ru) | 1998-09-14 | 2004-04-29 | Рэнбакси Лабораториз Лимитед | Лекарственная форма для контролируемого высвобождения ципрофлоксацина для приема один раз в день |
| US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
| AU2003216058A1 (en) | 2002-01-14 | 2003-07-30 | The Board Of Trustees Of The University Of Illinois | Mammalian neural stem cells, compositions and uses thereof |
-
2001
- 2001-11-19 ES ES01274758T patent/ES2259011T3/es not_active Expired - Lifetime
- 2001-11-19 DK DK01274758T patent/DK1461017T3/da active
- 2001-11-19 AU AU2002224011A patent/AU2002224011B2/en not_active Ceased
- 2001-11-19 WO PCT/IN2001/000204 patent/WO2003043607A1/en active IP Right Grant
- 2001-11-19 AT AT01274758T patent/ATE319434T1/de not_active IP Right Cessation
- 2001-11-19 DE DE60117712T patent/DE60117712T2/de not_active Expired - Fee Related
- 2001-11-19 PT PT01274758T patent/PT1461017E/pt unknown
- 2001-11-19 US US10/495,961 patent/US8192755B2/en not_active Expired - Fee Related
- 2001-11-19 BR BR0117171-2A patent/BR0117171A/pt not_active Application Discontinuation
- 2001-11-19 EP EP01274758A patent/EP1461017B1/en not_active Expired - Lifetime
-
2006
- 2006-06-05 CY CY20061100721T patent/CY1105365T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0117171A (pt) | 2004-10-26 |
| AU2002224011B2 (en) | 2008-05-01 |
| US20050031685A1 (en) | 2005-02-10 |
| EP1461017A1 (en) | 2004-09-29 |
| US8192755B2 (en) | 2012-06-05 |
| EP1461017B1 (en) | 2006-03-08 |
| ATE319434T1 (de) | 2006-03-15 |
| PT1461017E (pt) | 2006-07-31 |
| ES2259011T3 (es) | 2006-09-16 |
| DE60117712D1 (de) | 2006-05-04 |
| WO2003043607A1 (en) | 2003-05-30 |
| DE60117712T2 (de) | 2006-11-16 |
| DK1461017T3 (da) | 2006-06-19 |
| AU2002224011A1 (en) | 2003-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1105365T1 (el) | Μια φαρμακευτικη συνθεση για ελεγχομενη εκλυση ενος αντιβιοτικου της β-λακταμης | |
| DE60203894D1 (de) | Herstellung von nichtkristallinem atorvastatin?calcium | |
| ZA9711607B (en) | Novel cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them. | |
| HUP0302571A2 (hu) | Szerves vegyületek keverékét tartalmazó gyógyszerkészítmény légúti betegségek kezelésére | |
| HUP0400636A2 (hu) | Azetidinszármazékokat tartalmazó gyógyszerkészítmények, új azetidinszármazékok és előállításuk | |
| HRP20060276B1 (hr) | 6-0-supstituirani ketolidi antibakterijskog djelovanja | |
| WO2001042219A3 (en) | Novel substituted phenanthridinones and methods of use thereof | |
| ZA200603538B (en) | P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same | |
| DE69713148D1 (de) | Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen | |
| CY1107069T1 (el) | Χρηση των αναστολεων της cox-2 σαν ανοσοδιεγερτες στη θεραπεια του hiv ή του aids | |
| PA8465901A1 (es) | Nuevos derivados de la eritromicina | |
| CY1105235T1 (el) | Συνθεσεις λασοφοξιφενης | |
| ATE359777T1 (de) | Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate | |
| NO980380D0 (no) | Karbapenem antibiotika, preparat og fremstillingsmetode | |
| SE9903997D0 (sv) | New compounds | |
| TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
| WO2004096823A3 (en) | Novel ketolide derivatives | |
| EA200401455A1 (ru) | Производные бензоксазина в качестве модуляторов 5-htи их применение | |
| HRP20030050B1 (en) | Sustained-release preparations of quinolone antibiotics and method for preparation thereof | |
| MY138826A (en) | 2,7-substituted indoles | |
| AU2003223340A1 (en) | Certain pharmaceutically useful substituted aminoalkyl heterocycles | |
| HUP0500842A2 (hu) | Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra | |
| MX2023001725A (es) | Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmaceuticos de los mismos. | |
| NO20031410L (no) | Anvendelse av distamycinderivater for fremstilling av medikamenter | |
| MXPA05010783A (es) | Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos. |